Omar  Ishrak net worth and biography

Omar Ishrak Biography and Net Worth

Chairman of Medtronic
Omar Ishrak serves as Executive Chairman and Chairman of the Board of Directors at Medtronic, and Chairman of the Board of Directors at Intel. Omar was CEO of Medtronic from June 2011 – April 2020.

Medtronic is the world’s leading medical technology company, with $29 billion in annual revenue, 90,000 employees and operations reaching more than 150 countries worldwide. Medtronic offers technologies and solutions to treat a wide range of medical conditions, including cardiac and vascular diseases, respiratory, neurological and spinal conditions, diabetes, and more. The Medtronic Mission is to use technology to alleviate pain, restore health, and extend life for millions of people around the world.

As CEO, Omar focused the company around three long-term growth strategies of Therapy Innovation, Globalization, and Economic Value. In addition, Omar engineered the acquisition of Covidien — a $10 billion global manufacturer of surgical products and supplies — the largest medical technology acquisition in the history of the industry. Medtronic is now executing on the strongest technology pipeline in company history, bringing to market a long list of innovations that will improve the lives of even more patients around the world and help healthcare systems become more efficient.

Omar is also passionate about inclusion and diversity. He established Medtronic’s Diversity Networks, and during his tenure the company has been recognized for its commitment to fostering an inclusive and diverse culture. In 2020, Medtronic was awarded the prestigious Catalyst Award, which is given to corporations driving global change by building workplaces that work for women.

In January 2020, Omar was named independent Chairman of the Board of Directors of Intel. Omar has served as a member of the Intel board since March 2017. Intel is a global technology company with $72 billion in annual revenue in FY19. Intel is an industry leader that creates world-changing technology that enables global progress and enriches lives. Inspired by Moore’s Law, Intel works to advance the design and manufacturing of semiconductors to help address customer challenges. By embedding intelligence in the cloud, network, edge and every kind of computing device, Intel harnesses the potential of data to transform business and society for the better.

Prior to joining Medtronic, Omar was President and CEO of GE Healthcare Systems. He held several other roles at GE during his 16-year tenure, including serving as an Officer and a Senior Vice President. Earlier in his career, Omar amassed 13 years of technology development and business management experience, holding leadership positions at Diasonics/Vingmed, and various product development and engineering positions at Philips Ultrasound.

He grew up in Bangladesh and earned a Bachelor of Science degree and Ph.D. in Electrical Engineering from the University of London, King's College. He is also a Fellow of King’s College. He was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2016 and was elected to the National Academy of Engineering in 2020.

Omar serves on the Board of Directors of the Cleveland Clinic, a nonprofit academic medical center that is consistently named as one of the nation’s best hospitals by U.S. News & World Report. Omar is also a member of the Board of Trustees of the Asia Society, the leading educational organization dedicated to promoting mutual understanding and strengthening partnerships among peoples, leaders and institutions of Asia and the United States in a global context. In addition, he is a member of the Minnesota Public Radio Board of Trustees.

What is Omar Ishrak's net worth?

The estimated net worth of Omar Ishrak is at least $7,287.64 as of January 30th, 2023. Mr. Ishrak owns 86 shares of Medtronic stock worth more than $7,288 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Ishrak may own. Learn More about Omar Ishrak's net worth.

How do I contact Omar Ishrak?

The corporate mailing address for Mr. Ishrak and other Medtronic executives is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. Medtronic can also be reached via phone at (531) 438-1700 and via email at [email protected]. Learn More on Omar Ishrak's contact information.

Has Omar Ishrak been buying or selling shares of Medtronic?

Omar Ishrak has not been actively trading shares of Medtronic within the last three months. Most recently, Omar Ishrak sold 763 shares of the business's stock in a transaction on Friday, October 9th. The shares were sold at an average price of $108.40, for a transaction totalling $82,709.20. Following the completion of the sale, the chairman now directly owns 561,032 shares of the company's stock, valued at $60,815,868.80. Learn More on Omar Ishrak's trading history.

Who are Medtronic's active insiders?

Medtronic's insider roster includes Richard Anderson (Director), Michael Coyle (EVP), Gary Ellis (EVP), Hooman Hakami (EVP), Bryan Hanson (EVP), Omar Ishrak (Chairman), Richard Kuntz (SVP), Bradley Lerman (SVP), John Liddicoat (EVP), Michael Marinaro (EVP), Geoffrey Martha (CEO), Karen Parkhill (CFO), Sean Salmon (EVP), Gregory Smith (EVP), Carol Surface (SVP), Rob Ten Hoedt (EVP), Brett Wall (EVP), Brett Wall (EVP), and Robert White (EVP). Learn More on Medtronic's active insiders.

Are insiders buying or selling shares of Medtronic?

During the last year, insiders at the medical technology company sold shares 4 times. They sold a total of 55,659 shares worth more than $4,695,766.41. The most recent insider tranaction occured on June, 7th when CEO Geoffrey Martha sold 19,113 shares worth more than $1,601,096.01. Insiders at Medtronic own 0.2% of the company. Learn More about insider trades at Medtronic.

Information on this page was last updated on 6/7/2024.

Omar Ishrak Insider Trading History at Medtronic

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/9/2020Sell763$108.40$82,709.20561,032View SEC Filing Icon  
2/20/2020Buy8,771$110.87$972,440.77View SEC Filing Icon  
1/9/2019Buy12,000$84.05$1,008,600.00View SEC Filing Icon  
9/15/2017Sell140,407$81.63$11,461,423.41668,503View SEC Filing Icon  
3/15/2017Sell95,000$82.82$7,867,900.00645,616View SEC Filing Icon  
9/15/2016Sell61,925$84.93$5,259,290.25565,916View SEC Filing Icon  
3/17/2016Sell23,799$76.15$1,812,293.85601,838View SEC Filing Icon  
9/15/2015Sell20,000$69.43$1,388,600.00526,824View SEC Filing Icon  
3/13/2015Sell20,000$76.24$1,524,800.00View SEC Filing Icon  
3/14/2014Sell10,000$59.12$591,200.00607,192View SEC Filing Icon  
9/13/2013Sell10,000$53.58$535,800.00611,713View SEC Filing Icon  
See Full Table

Omar Ishrak Buying and Selling Activity at Medtronic

This chart shows Omar Ishrak's buying and selling at Medtronic by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medtronic Company Overview

Medtronic logo
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $84.74
Low: $83.92
High: $85.13

50 Day Range

MA: $89.17
Low: $84.11
High: $92.27

2 Week Range

Now: $84.74
Low: $75.96
High: $92.68

Volume

5,449,876 shs

Average Volume

6,261,737 shs

Market Capitalization

$108.68 billion

P/E Ratio

25.91

Dividend Yield

3.29%

Beta

0.84